Equities

Aethlon Medical Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Aethlon Medical Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)2.23
  • Today's Change0.09 / 4.21%
  • Shares traded45.46k
  • 1 Year change-96.21%
  • Beta1.6170
Data delayed at least 15 minutes, as of Feb 06 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Aethlon Medical, Inc. is a clinical-stage medical device company. The Company is focused on advancing the Hemopurifier (HP), a clinical-stage immunotherapeutic device intended for applications in cancer, life-threatening viral infections, and organ transplantation and other areas of significant unmet needs. In pre-clinical studies, the Hemopurifier has exhibited the capacity to remove harmful extracellular vesicles (EVs) and enveloped viruses from biological fluids, utilizing its proprietary lectin-based mechanism. These extracellular vesicles have been implicated in disease processes such as immune suppression and metastasis in cancer as well as in the progression of severe life-threatening infectious diseases. The United States Food and Drug Administration (FDA) has designated the Hemopurifier as a Breakthrough Device for the treatment of individuals with advanced or metastatic cancer who are unresponsive to or intolerant of standard of care therapy.

  • Revenue in USD (TTM)0.00
  • Net income in USD-11.26m
  • Incorporated1991
  • Employees9.00
  • Location
    Aethlon Medical Inc11555 Sorrento Valley Road, Suite 203SAN DIEGO 92121United StatesUSA
  • Phone+1 (619) 941-0360
  • Fax+1 (619) 941-0361
  • Websitehttps://www.aethlonmedical.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Leafbuyer Technologies Inc5.84m205.18k1.20m12.005.85----0.20580.0020.0020.0583-0.01426.35--71.02486,275.0022.33-44.28----44.0437.833.52-21.61--3.07----15.5420.68136.74-27.51----
Sigyn Therapeutics Inc0.00-3.22m1.20m4.00---------2.01-2.010.00-3.690.00----0.00-1,144.23-590.29---------------3.44--------19.43------
Nu-Med Plus Inc0.00-54.13k1.28m2.00---------0.0006-0.00060.00-0.00310.00----0.00-910.51-451.95---------------8.61--------45.55------
Escalon Medical Corp11.94m-200.38k1.33m39.00--1.29--0.1115-0.0436-0.04361.110.22592.573.677.31306,156.90-2.201.53-4.993.4845.3843.87-0.85520.70260.979-1.960.1335--0.53955.09115.88---42.12--
Zynex Inc108.20m-73.96m1.52m1.00k------0.014-2.43-2.433.49-1.341.262.207.64108,202.00-86.3110.48-203.5512.4271.9079.57-68.357.510.3174-12.223.19--4.3633.44-69.24-20.6129.29--
Aethlon Medical Inc0.00-11.26m2.08m9.00--0.2835-----56.69-56.690.007.550.00----0.00-139.25-86.44-181.09-98.06-------3,662.04----0.00-------9.67------
Tivic Health Systems Inc482.00k-7.51m2.10m7.00--0.2469--4.35-9.87-9.870.59143.360.10022.0734.4368,857.14-156.00-118.40-178.18-148.80-58.095.50-1,557.26-610.995.86--0.00---33.6713.1831.40------
Work Medical Technology Group Ltd10.74m-3.71m2.16m229.00--0.0001--0.2007-2,871.58-2,871.587,811.598,868.19------46,903.67--------26.89---35.42--0.9802-8.870.4505---15.18---3,217.31------
Venus Concept Inc58.88m-54.61m2.19m292.00--0.8207--0.0373-46.93-46.9348.241.440.87941.213.13201,630.10-81.66-34.89-199.53-47.8164.3667.86-92.86-54.810.5934-6.680.9056---15.09-10.10-26.16---35.75--
Encision Inc6.30m-380.94k2.36m22.00--1.27--0.3751-0.0284-0.02840.50570.11051.662.277.98286,353.60-10.05-3.17-14.19-4.4052.6451.47-6.05-2.010.9127-5.690.1094---0.464-3.0968.17--8.09--
Autonomix Medical Inc0.00-16.69m2.44m8.00--0.3398-----5.08-5.080.001.040.00----0.00-250.94---316.15--------------0.00------26.03------
INVO Fertility Inc6.94m-27.13m2.51m28.00------0.3609-602.89-644.6750.028.630.387419.5026.14247,996.40-149.96-63.14-299.48-98.9639.1760.46-387.11-276.300.1022-10.360.2530--116.2534.57-16.33--9.88--
Avalon Globocare Corp1.40m-18.76m2.57m5.00------1.84-9.75-9.750.6074-1.100.0974--16.92279,216.00-131.94-76.04-1,379.37-114.3725.7023.19-1,355.20-888.890.1477-4.072.69--6.19-2.9252.69------
Fuse Medical Inc18.40m3.63m2.96m31.001.11--0.80140.16060.0360.0360.2307-0.00310.95930.70185.75593,671.9018.910.750448.451.3564.9554.9819.720.65520.3143-1.131.12---8.67-6.72295.1134.66----
Catheter Precision Inc730.00k-22.19m2.97m22.00--0.4323--4.07-37.38-37.380.93714.120.0281.646.3533,181.82-66.93-128.03-78.29-160.1292.60-242.70-2,393.84-15,268.880.4569-66.840.0449---4.98-19.8969.45---24.21--
Data as of Feb 06 2026. Currency figures normalised to Aethlon Medical Inc's reporting currency: US Dollar USD

Institutional shareholders

6.81%Per cent of shares held by top holders
HolderShares% Held
Ikarian Capital LLCas of 30 Sep 202515.37k2.02%
HRT Financial LPas of 30 Sep 202513.06k1.72%
Citadel Securities LLCas of 30 Sep 20259.51k1.25%
Renaissance Technologies LLCas of 30 Sep 20254.60k0.60%
Scientech Research LLCas of 30 Sep 20252.60k0.34%
Two Sigma Investments LPas of 30 Sep 20252.03k0.27%
XTX Markets LLCas of 30 Sep 20251.55k0.20%
Two Sigma Securities LLCas of 30 Sep 20251.47k0.19%
Geode Capital Management LLCas of 30 Sep 20251.35k0.18%
Tower Research Capital LLCas of 30 Sep 2025299.000.04%
More ▼
Data from 30 Sep 2025 - 30 Sep 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.